Transforming growth factor- β mediated regulation of epigenome is required for epithelial to mesenchymal transition associated features in liver cancer cells

Transforming growth factor- β mediated regulation of epigenome is required for epithelial to mesenchymal transition associated features in liver cancer cells

Hepatocellular carcinoma (HCC) frequently unfolds under an inflammatory condition, which is a hub for a plethora of cytokines. A better understanding of the cytokine functions and their contributions to disease development is key to design of future therapeutic strategies and reduction of global HCC...

Full description

Bibliographic Details
Main Authors:	Abhilasha Srivastava, Harshita Sharma, Shibasish Chowdhury, Rajdeep Chowdhury, Sudeshna Mukherjee
Format:	Article
Language:	English
Published:	Elsevier 2023-04-01
Series:	Heliyon
Subjects:	TGF-β EMT SMAD EZH2 H3K27me3
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844023018728

Similar Items

Interleukin-6 Induced Proliferation Is Attenuated by Transforming Growth Factor-β-Induced Signaling in Human Hepatocellular Carcinoma Cells
by: Abhilasha Srivastava, et al.
Published: (2022-01-01)

TGF-β1 induced deficiency of linc00261 promotes epithelial–mesenchymal-transition and stemness of hepatocellular carcinoma via modulating SMAD3
by: Zhanjun Chen, et al.
Published: (2022-02-01)

EZH2: a novel target for cancer treatment
by: Ran Duan, et al.
Published: (2020-07-01)

Sinomenine Relieves Airway Remodeling By Inhibiting Epithelial-Mesenchymal Transition Through Downregulating TGF-β1 and Smad3 Expression In Vitro and In Vivo
by: Hongjuan He, et al.
Published: (2021-11-01)

The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders
by: Jacopo Di Gregorio, et al.
Published: (2020-12-01)

Inhibition of TGF-β/Smad3 Signaling Disrupts Cardiomyocyte Cell Cycle Progression and Epithelial–Mesenchymal Transition-Like Response During Ventricle Regeneration
by: Yuanyuan Peng, et al.
Published: (2021-03-01)

Corrigendum: Inhibition of TGF-β/Smad3 Signaling Disrupts Cardiomyocyte Cell Cycle Progression and Epithelial–Mesenchymal Transition-Like Response During Ventricle Regeneration
by: Yuanyuan Peng, et al.
Published: (2021-05-01)

Epigenetic Regulation of EMT (Epithelial to Mesenchymal Transition) and Tumor Aggressiveness: A View on Paradoxical Roles of KDM6B and EZH2
by: Camille Lachat, et al.
Published: (2018-12-01)

Lyn regulates epithelial–mesenchymal transition in CS-exposed model through Smad2/3 signaling
by: Xiaobo Liang, et al.
Published: (2019-09-01)

The Epithelial-to-Mesenchymal Transition-Like Process Induced by TGF-β1 Enhances Rubella Virus Binding and Infection in A549 Cells via the Smad Pathway
by: Ngan Thi Kim Pham, et al.
Published: (2021-03-01)

Inhibitory Effects of 3-Cyclopropylmethoxy-4-(difluoromethoxy) Benzoic Acid on TGF-β1-Induced Epithelial–Mesenchymal Transformation of In Vitro and Bleomycin-Induced Pulmonary Fibrosis In Vivo
by: Tianxiao Sun, et al.
Published: (2023-03-01)

Cyclin‐dependent kinase subunit2 (CKS2) promotes malignant phenotypes and epithelial‐mesenchymal transition‐like process in glioma by activating TGFβ/SMAD signaling
by: Fan Feng, et al.
Published: (2023-03-01)

OLFM2 promotes epithelial-mesenchymal transition, migration, and invasion in colorectal cancer through the TGF-β/Smad signaling pathway
by: Yong Tang, et al.
Published: (2024-02-01)

Redirecting RNA splicing by SMAD3 turns TGF-β into a tumor promoter
by: Veenu Tripathi, et al.
Published: (2017-01-01)

MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGFβ/SMAD Signaling Pathway in Colorectal Cancer Metastasis
by: Hanqing Hu, et al.
Published: (2018-04-01)

EZH2/H3K27Me3 and phosphorylated EZH2 predict chemotherapy response and prognosis in ovarian cancer
by: Si Sun, et al.
Published: (2020-05-01)

Divergent Effects of EZH1 and EZH2 Protein Expression on the Prognosis of Patients with T-Cell Lymphomas
by: Franziska Lea Schümann, et al.
Published: (2021-12-01)

Altered expression of epigenetic modifiers EZH2, H3K27me3, and DNA methyltransferases in meningiomas – prognostic biomarkers for routine practice
by: Swagatika Samal, et al.
Published: (2020-06-01)

Effect of aging on the formation and growth of colonic epithelial organoids by changes in cell cycle arrest through TGF-β-Smad3 signaling
by: Min Kyoung Jo, et al.
Published: (2023-07-01)

Targeting SMAD-Dependent Signaling: Considerations in Epithelial and Mesenchymal Solid Tumors
by: Farhana Runa, et al.
Published: (2024-03-01)

Catalpol Attenuates Pulmonary Fibrosis by Inhibiting Ang II/AT1 and TGF-β/Smad-Mediated Epithelial Mesenchymal Transition
by: Qun Yu, et al.
Published: (2022-05-01)

MicroRNA-527 inhibits TGF-β/SMAD induced epithelial-mesenchymal transition via downregulating SULF2 expression in non-small-cell lung cancer
by: Wei Huo, et al.
Published: (2019-05-01)

Inhibition of Polycomb Repressive Complex 2 activity reduces trimethylation of H3K27 and affects development in Arabidopsis seedlings
by: Veronica Ruta, et al.
Published: (2019-10-01)

Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer
by: Hui-Wen Yang, et al.
Published: (2023-11-01)

Upregulation of Enhancer of Zeste Homolog 2 (EZH2) with Associated pERK Co-Expression and PRC2 Complex Protein SUZ12 Correlation in Adult T-Cell Leukemia/Lymphoma
by: Jiani Chai, et al.
Published: (2024-02-01)

Ezh2 Inhibits Replicative Senescence of Atrial Fibroblasts Through Promotion of H3K27me3 in the Promoter Regions of CDKN2a and Timp4 Genes
by: Li Y, et al.
Published: (2022-08-01)

EZH2-mediated H3K27me3 is a predictive biomarker and therapeutic target in uveal melanoma
by: Chen Hou, et al.
Published: (2022-10-01)

Inhibition of EZH2 primes the cardiac gene activation via removal of epigenetic repression during human direct cardiac reprogramming
by: Yawen Tang, et al.
Published: (2021-05-01)

C-phycocyanin inhibits epithelial-to-mesenchymal transition in Caski cells
by: Huanhuan Ji, et al.
Published: (2020-07-01)

LncRNAs as epigenetic regulators of epithelial to mesenchymal transition in pancreatic cancer
by: Yan Ma, et al.
Published: (2022-07-01)

Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors
by: Haruka Shinohara, et al.
Published: (2022-12-01)

SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal Adenocarcinoma
by: Julie Dardare, et al.
Published: (2020-05-01)

Epithelial–Mesenchymal Transition by Synergy between Transforming Growth Factor-β and Growth Factors in Cancer Progression
by: Masao Saitoh
Published: (2022-09-01)

Flotillin1 promotes EMT of human small cell lung cancer via TGF-β signaling pathway
by: Lianmei Zhao, et al.
Published: (2018-12-01)

Non-canonical functions of EZH2 in cancer
by: Sarah M. Zimmerman, et al.
Published: (2023-08-01)

DNMT1 modulates interneuron morphology by regulating Pak6 expression through crosstalk with histone modifications
by: Judit Symmank, et al.
Published: (2018-05-01)

Emerin anchors Msx1 and its protein partners at the nuclear periphery to inhibit myogenesis
by: Zhangjing Ma, et al.
Published: (2019-04-01)

Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2)
by: Changchien Yi-Che, et al.
Published: (2012-10-01)

Deregulation of Polycomb Repressive Complex-2 in Mantle Cell Lymphoma Confers Growth Advantage by Epigenetic Suppression of cdkn2b
by: Christos Demosthenous, et al.
Published: (2020-07-01)

DZNep promotes mouse bone defect healing via enhancing both osteogenesis and osteoclastogenesis
by: Xiankun Cao, et al.
Published: (2021-12-01)